Yeztugo
Payments companies reported to CMS as associated with Yeztugo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Yeztugo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Yeztugo
These are the largest totals companies reported as associated with Yeztugo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wilfredo Giordano-Perez | Johnston, RI | Family Medicine | $68,519.52 |
| Noah Lee | Oakland Park, FL | Family Medicine | $39,736.48 |
| Nasser Mohamed | San Francisco, CA | Family Medicine | $38,698.34 |
| Nicholaos Bellos | Dallas, TX | Internal Medicine | $37,146.47 |
| Theo Hodge | Washington, DC | Infectious Disease | $36,292.97 |
| Antonio Urbina | New York, NY | Infectious Disease | $35,035.11 |
| Karam Mounzer | Philadelphia, PA | Infectious Disease | $29,299.23 |
| Ashton Chase | Bakersfield, CA | Family | $28,087.45 |
| Caleb Youngblood | Berkley, MI | Medical | $27,726.48 |
| William King | Los Angeles, CA | Internal Medicine | $27,512.45 |
Prescribed Yeztugo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.